ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

In silico and in vivo demonstration of the regulatory mechanism of Qi-Ge decoction in treating NAFLD

Peng, Chong; Li, Jing; Ke, Xuehong; Liu, Fengbin*; Huang, Ke-er*广州中医药大学; 1
Annals of Medicine2023-12-12DOI: 10.1080/07853890.2023.2200258
1被引10阅读
引用收藏
分享

摘要

Background Nonalcoholic fatty liver disease (NAFLD), a chronic and progressive liver disease, often causes steatosis and steatohepatitis. Qi-Ge decoction (QGD) shows a good effect against NAFLD in the clinic. But the molecular mechanism for QGD in improving NAFLD is unknown. Purpose This study explored the molecular mechanism of QGD in NAFLD model rats using comprehensive network pharmacology, molecular docking and in vivo verification strategies. Methods Active components and targets of QGD were obtained from public database. The overlapped genes between QGD and NAFLD targets were analyzed by enrichment analysis. Active components and targets were used to predict molecular docking analysis. Finally, seven key targets were screened out and the gene expression were verified in the NAFLD rat's liver tissues after QGD treatment. Results Fifty-eight common QGD therapeutic targets were associated with NAFLD. Molecular docking demonstrated that seven targets had strong binding ability for the corresponding active ingredients. GO analysis identified 18 biological process entries, which were mainly related to regulation of lipid storage, lipid localization and peptide transport. KEGG analysis identified multiple signaling pathways, which were mainly associated with tumor necrosis factor signaling and NAFLD. In vivo data confirmed that the effect of QGD in the treatment of NAFLD was mainly exerted through improving liver steatosis and inflammatory cell infiltration. Additionally, QGD upregulated the expression of MAPK8 and ESR1 and downregulated the transcriptional expression of IL6, VEGFA, CASP3, EGFR and MYC. These targets may affect lipid metabolism by regulating lipid storage and inflammation. Conclusion The integration of results obtained in silico and in vivo indicated that QGD regulates multiple targets, biological processes and signaling pathways in NAFLD, which may represent a complex molecular mechanism by which QGD improves NAFLD. Key messages QGD intervention is related to multiple biological processes such as inflammation, oxidation and cell apoptosis in NAFLD. Lipid and atherosclerosis, TNF signaling pathway, IL-17 signaling pathway, non-alcoholic fatty liver disease and AGE-RAGE signaling pathway in diabetic complications are the main pathways for QGD intervention NAFLD. The active components of QGD can form good binding with relevant target proteins through intermolecular forces, exhibiting excellent docking activity.

学科与关键词

关键词
Qi-ge decoctionNAFLDnetwork pharmacologymolecular dockingin silico studyin vivo validation
相关
加载中…
  • Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD
    Fan, Simin; Zhou, Zunming; Ye, Jintong; Li, Yanfang; Huang, Keer*; Ke, Xuehong*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 9739032.被引 1
  • Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking
    Sun, Yuanfang; Wang, Leqi; Du, Lijing; Yu, Huajun*; Tian, Yan; Jin, Huizi; Li, Shasha; Yan, Shikai; Xiao, Xue*TECHNOLOGY AND HEALTH CARE, 2023, 31: S209-S221.
  • Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
    Lei, Sisi; Zhao, Shuai; Huang, Xiaoyan; Feng, Yuchao; Li, Zhishang; Chen, Li; Huang, Peiying; Guan, Hansu; Zhang, Haobo; Wu, Qihua; Chen, Bojun*Frontiers in Pharmacology, 2022, 13: 967623.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Medicine
发表日期
2023-12-12
卷期
第 55 卷, 第 1 期
页码
2200258
DOI
10.1080/07853890.2023.2200258
语言
ENGLISH
成果收录
SCIE

作者

  • P

    Peng, Chong (第一作者)

    1 · guangzhou univ chinese med

  • L

    Li, Jing

    guangzhou univ chinese med · 1

查看全部 5 位作者收起作者
  • K

    Ke, Xuehong

    1 · guangzhou univ chinese med

  • L

    Liu, Fengbin (通讯)

    1 · guangzhou univ chinese med

  • H

    Huang, Ke-er (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417